术中低体温在即刻假体乳房再造围术期阿片类药物需求中的作用
该回顾性研究纳入2019—2023年536例(835侧)即刻假体乳房再造患者,按术中大部分时间体温<36.0 °C或≥36.0 °C分为低体温组与正常体温组。低体温组术中及术后阿片类药物需求均低于正常体温组,且调整后需高剂量阿片类药物的几率降低66%。作者认为低体温与围术期阿片类药物需求减少相关,未来需进一步研究加温方案的理想温度阈值。
要点
- 低体温组术中阿片需求88.4 MMEs,低于正常体温组99.1 MMEs(P=0.007)。
- 低体温组术后阿片需求45.6 MMEs,低于正常体温组56.8 MMEs(P=0.006)。
- 调整混杂后低体温组需高剂量阿片类药物(≥100 MMEs)的几率降低66%(P=0.007)。
核心结论
- 低体温与即刻假体乳房再造患者围术期阿片类药物需求减少相关。
- 作者建议未来研究进一步探讨加温方案的理想温度阈值以减少术后疼痛。
研究设计与样本
- 回顾性病历审查,纳入2019—2023年接受即刻假体乳房再造的患者。
- 按术中大部分时间体温<36.0 °C(低体温组)或≥36.0 °C(正常体温组)分组。
- 共纳入536例患者(835侧乳房),其中低体温组135例(25.1%)。
主要发现
- 低体温组术中阿片类药物需求平均88.4 MMEs,低于正常体温组99.1 MMEs(P=0.007)。
- 低体温组术后阿片类药物需求平均45.6 MMEs,低于正常体温组56.8 MMEs(P=0.006)。
- 术中平均体温(B=14.6,P=0.004)和最低体温(B=10.4,P=0.038)直接预测更高的阿片类药物需求。
- 术中体温低于36 °C的时间百分比越高(B=-27.6,P=0.004),预测的阿片类药物需求越低。
- 调整患者和手术特征差异后,低体温组需高剂量阿片类药物(≥100 MMEs)的几率降低66%(P=0.007)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The relationship between perioperative temperatures and postoperative pain is unknown. The present study investigated the relationship of intraoperative hypothermia and perioperative opioid requirements after immediate implant-based breast reconstruction. METHODS: A retrospective chart review was conducted on patients undergoing immediate implant-based breast reconstruction from 2019-2023. Patients were classified into the hypothermic group (majority of procedure <36.0 °C) or normothermic group (majority of procedure ≥36.0 °C). Cumulative inpatient opioid requirements (morphine milli-equivalents [MMEs]) and frequency of patients requiring "high-dose opioids" (≥100 MMEs) were collected and compared between the groups. RESULTS: In total, 536 patients (835 breasts) were included, among whom 135 (25.1%) were hypothermic. The hypothermic group had lower mean intraoperative (88.4 vs. 99.1 MMEs, P = 0.007) and postoperative (45.6 vs. 56.8 MMEs, P = 0.006) than the normothermic group. Mean (B = 14.6, P = 0.004) and nadir (B = 10.4, P = 0.038) intraoperative temperatures directly predicted higher opioid requirements while higher percentages of the procedure time spent under 36 °C (B = -27.6, P = 0.004) predicted lower opioid requirements. The hypothermic group was associated with 66% decreased odds of requiring high-dose opioids after adjusting for differences in patient and operative characteristics (P = 0.007). CONCLUSION: Hypothermia is associated with decreased perioperative opioid requirements. Future studies should further investigate ideal temperature thresholds for warming protocols to minimize postoperative pain.
引用
- Wang CY, Shah R, Frost J, et al. Understanding the role of intraoperative hypothermia in perioperative opioid requirements in immediate implant-based breast reconstruction. J Plast Reconstr Aesthet Surg. 2024. PMID: 39303340. doi:10.1016/j.bjps.2024.08.074
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。